Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Chiodo

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
HIV Clinical Trials|February 3, 2006
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapineRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Metabolic Syndrome and Related Disorders|March 29, 2008
Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral TherapyLeonardo Calza, Roberto Manfredi, Francesco Chiodo
Journal of Biological Regulators and Homeostatic Agents|December 20, 2007
Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administrationRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|January 27, 2007
[HIV infection: emerging issues and new challenges]Leonardo Calza, Roberto Manfredi, Francesco Chiodo
The Journal of Antimicrobial Chemotherapy|December 3, 2003
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patientsLeonardo Calza, Roberto Manfredi, Francesco Chiodo
Le Infezioni in Medicina|February 27, 2004
Multiple AIDS-related malignancies just in the era of potent antiretroviral therapy. A rare but intriguing findingRoberto Manfredi, Leonardo Calza, Francesco Chiodo
AIDS (London, England)|December 4, 2004
First-line efavirenz versus lopinavir-ritonavir-based highly active antiretroviral therapy for naive patientsRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|June 3, 2005
[The role of a novel antiretroviral class (fusion inhibitors) in the treatment of advanced HIV infection. Preliminary experience with enfuvirtide]Roberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|May 5, 2006
[Screening of adult patients with fever of unknown origin. A prospective study on the role of primary cytomegalovirus infection]Roberto Manfredi, Leonardo Calza, Francesco Chiodo
International Journal of Antimicrobial Agents|October 3, 2003
AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problemsRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
HIV Clinical Trials|February 3, 2006
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapineRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Metabolic Syndrome and Related Disorders|March 29, 2008
Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral TherapyLeonardo Calza, Roberto Manfredi, Francesco Chiodo
Journal of Biological Regulators and Homeostatic Agents|December 20, 2007
Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administrationRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|January 27, 2007
[HIV infection: emerging issues and new challenges]Leonardo Calza, Roberto Manfredi, Francesco Chiodo
The Journal of Antimicrobial Chemotherapy|December 3, 2003
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patientsLeonardo Calza, Roberto Manfredi, Francesco Chiodo
Le Infezioni in Medicina|February 27, 2004
Multiple AIDS-related malignancies just in the era of potent antiretroviral therapy. A rare but intriguing findingRoberto Manfredi, Leonardo Calza, Francesco Chiodo
AIDS (London, England)|December 4, 2004
First-line efavirenz versus lopinavir-ritonavir-based highly active antiretroviral therapy for naive patientsRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|June 3, 2005
[The role of a novel antiretroviral class (fusion inhibitors) in the treatment of advanced HIV infection. Preliminary experience with enfuvirtide]Roberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|May 5, 2006
[Screening of adult patients with fever of unknown origin. A prospective study on the role of primary cytomegalovirus infection]Roberto Manfredi, Leonardo Calza, Francesco Chiodo
International Journal of Antimicrobial Agents|October 3, 2003
AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problemsRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Pageof 11